https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01735
Nivolumab, Nab-paclitaxel, and Carboplatin Induction Chemotherapy Followed by Response-Based...
Nivolumab, Nab-paclitaxel, and Carboplatin Induction Chemotherapy Followed by Response-Based Locoregional Therapy in Treating Patients with Locally Advanced...
nab paclitaxelinduction chemotherapynivolumabcarboplatin
https://www.nice.org.uk/guidance/awaiting-development/gid-ta11591
Project information | Zolbetuximab with nab-paclitaxel and gemcitabine for untreated claudin...
Zolbetuximab with nab-paclitaxel and gemcitabine for untreated claudin 18.2-positive metastatic pancreatic cancer [TSID12040]
project informationnab paclitaxelzolbetuximab
https://www.epo.org/de/boards-of-appeal/decisions/t141556eu2
T 1556/14 (nab-Paclitaxel combinations/ABRAXIS) vom 15.10.2020
nab paclitaxel15 10155614
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-relacorilant-nab-paclitaxel-platinum-resistant-epithelial-ovarian-fallopian-tube-or?
FDA approves relacorilant with nab-paclitaxel for platinum-resistant epithelial ovarian, fallopian...
FDA approves relacorilant with nab-paclitaxel for platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer
nab paclitaxel
https://www.cancerresearchuk.org/about-cancer/treatment/drugs/atezolizumab-nab-paclitaxel
Atezolizumab and nab-paclitaxel | Cancer Research UK
Atezolizumab and nab-paclitaxel are a combination of cancer drugs for the treatment of triple negative breast cancer. Find out about how you about having it...
nab paclitaxelcancer researchatezolizumabuk
https://www.mdedge.com/content/nab-paclitaxel-drives-response-rate-metastatic-bladder-cancer
Nab-Paclitaxel Drives Up Response Rate in Metastatic Bladder Cancer | MDedge
nab paclitaxelresponse ratebladder cancerdrives
https://www.hmpgloballearningnetwork.com/site/onc/videos/relacorilant-plus-nab-paclitaxel-patients-platinum-resistant-ovarian-cancer
Relacorilant Plus Nab-Paclitaxel for Patients With Platinum-Resistant Ovarian Cancer
Brian Slomovitz, MD, discusses results from the ROSELA trial which led to the recent FDA approval of relacorilant plus nab-paclitaxel for patients with...
nab paclitaxelfor patientsrelacorilantplus
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-01762
Combination Chemotherapy and Nab-Paclitaxel in Treating Patients with Advanced or Metastatic...
Combination Chemotherapy and Nab-Paclitaxel in Treating Patients with Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed...
combination chemotherapynab paclitaxel
https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-nab-paclitaxel-with-gemcitabine-for-cancer-of-pancreas-that-has-spread-siege
A trial of nab-paclitaxel and gemcitabine for cancer of the pancreas that has spread (SIEGE)
This trial looked at 2 different ways of having nab-paclitaxel and gemcitabine chemotherapy for pancreatic cancer that has spread to another part of the body.
https://www.mayo.edu/research/clinical-trials/cls-20127205
Evaluate Risk/Benefit Of Nab Paclitaxel In Combination With Gemcitabine And Carboplatin Compared To...
Learn more about services at Mayo Clinic.
https://www.mayo.edu/research/clinical-trials/cls-20146654
A Phase 1/2 Trial of Gemcitabine Plus Nab-paclitaxel With or Without FG-3019 as Neoadjuvant...
Learn more about services at Mayo Clinic.
https://www.esmo.org/oncology-news/clinical-activity-of-elraglusib-with-gemcitabine-plus-nab-paclitaxel-in-first-line-treatment-of-patients-with-metastatic-pancreatic-ductal-adenocarcinoma
Clinical Activity of Elraglusib with Gemcitabine Plus Nab-paclitaxel in First-Line Treatment of...